Background

Text Resize

-A +A
1498
1499
1500
1501
1502

Donate Now

Home

Printer-friendly versionPDF version Share/Save
Listen to this page using ReadSpeaker

Foundation News

The Massachusetts-based company Advanced Cell Technology is testing the therapy in patients with Stargardt disease and AMD.
Supported by the Foundation, the Irish company has recently taken the crucial steps necessary to getting a treatment to patients.
The two organizations will provide up to $50 million in new funding and resources to support up to 30 physician-scientists.
An emerging gene therapy research project for a blinding retinal disease that strikes children is receiving $900,000 from Genzyme, an international pharmaceutical company.

OUR BLOG - EYE ON THE CURE

Events Calendar